Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4426053 | 0.97 | THRB (0.50) | THRBLMNA | |
| SCHEMBL1021902 | 0.97 | THRB (0.50) | THRBLMNA | |
| SCHEMBL1221730 | 0.81 | THRB (0.42) | THRBLMNA | |
| SCHEMBL22011346 | 0.78 | THRB (0.32) | THRB | |
| SCHEMBL1275959 | 0.78 | THRB (0.43) | THRBLMNA | |
| SCHEMBL9717162 | 0.75 | THRB (0.42) | THRBLMNA | |
| SCHEMBL1221763 | 0.75 | THRB (0.42) | THRBLMNA | |
| SCHEMBL29616992 | 0.75 | THRB (0.48) | THRBLMNA | |
| SCHEMBL31470114 | 0.75 | THRB (0.48) | THRBLMNA | |
| SCHEMBL31470129 | 0.75 | THRB (0.48) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3664770-B1 | THERAPEUTIC GAS INFUSED COSMETIC AND METHODS OF INFUSION | TETROUS INC (US) | 2024-12-04 | — | — | EP | claimed |
| WO-2024097997-A2 | PHOTOACOUSTIC VAPORIZATION OF EXOSKELETAL AND ENDOSKELETAL DROPLETS | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2024-05-10 | — | — | WO | claimed |
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-09-01 | — | — | US | claimed |
| US-20200101014-A1 | Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2020-04-02 | — | — | US | claimed |
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2019-10-01 | — | — | US | claimed |
| WO-2018187236-A1 | STABLE THERANOSTIC AND THERAPEUTIC NANOEMULSIONS USING TRIPHILIC SEMIFLUORINATED AMPHIPHILES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2018-10-11 | — | — | WO | claimed |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-04-13 | — | — | US | claimed |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-02-23 | — | — | US | claimed |
| EP-2099408-B1 | FLUOROPOLYMER-BASED EMULSIONS FOR THE INTRAVENOUS DELIVERY OF FLUORINATED VOLATILE ANESTHETICS | WISCONSIN ALUMNI RES FOUND (US) | 2016-10-05 | — | — | EP | claimed |
| WO-2015164756-A1 | FLUOROPOLYMER EMULSIONS WITH PERHALOGENATED STABILIZER FOR THE DELIVERY OF HYDROPHOBIC DRUGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-10-29 | — | — | WO | claimed |
| WO-2000040252-A1 | NOVEL POLYMER FORMULATIONS CONTAINING PERFLUORINATED COMPOUNDS FOR THE ENGINEERING OF CELLS AND TISSUES FOR TRANSPLANTATION THAT IMPROVES CELL METABOLISM AND SURVIVAL, AND METHODS FOR MAKING SAME | BIOMM, INCORPORATED (US) | 2000-07-13 | — | — | WO | claimed |
| US-5989918-A | DETERMINING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION AND PHARMACOKINETICS OF TEST COMPOUND IN ISOLATED LIVE ORGAN USING FLUOROCARBON EMULSION AS BLOOD SUBSTITUTE, ADDING COMPOUND, DISRUPTING EMULSION OF SAMPLE, ANALYSIS | CHIRON CORPORATION (US) | 1999-11-23 | — | — | US | claimed |
| EP-0923733-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1999-06-23 | — | — | EP | claimed |
| WO-1998009166-A1 | METHOD FOR ANALYSING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION (ADME) AND PHARMACOKINETICS PROPERTIES OF COMPOUND MIXTURES | CHIRON CORPORATION (US) | 1998-03-05 | — | — | WO | claimed |
| EP-0515676-B1 | SYSTEM FOR OXYGENATION OF THE HEART USING SUBPERICARDIAL FLUIDS | MALLINCKRODT MEDICAL INC (US) | 1997-03-12 | — | — | EP | claimed |
| US-5595687-A | INJECTABLE FLUOROCARBON EMULSION USEFUL IN CORONARY ANGIOPLASTY, CANCER THERAPY | THOMAS JEFFERSON UNIVERSITY (US) | 1997-01-21 | — | — | US | claimed |
| EP-0666736-B1 | STABILIZATION OF FLUOROCARBON EMULSIONS | ALLIANCE PHARMA (US) | 1996-12-18 | — | — | EP | claimed |
| US-5085630-A | Treatment of hypoxic-ischemic neurologic tissue | THOMAS JEFFERSON UNIVERSITY (US) | 1992-02-04 | — | — | US | claimed |
| US-4981691-A | AMINO ACIDS | THOMAS JEFFERSON UNIVERSITY (US) | 1991-01-01 | — | — | US | claimed |
| EP-0118281-B1 | IMPROVEMENTS IN AND RELATING TO A METHOD OF DETECTING A CERTAIN GAS IN AN ANIMAL | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 1990-10-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10426727-B2 | Fluoropolymer emulsions with branched semifluorinated block copolymer or phospholipid surfactant for the delivery of hydrophobic drugs | FFAR3, FFAR1, FAU | THRB 1404/4885LMNA 2221/4885 |
| US-20170049699-A1 | Fluoropolymer Emulsions with Branched Semifluorinated Block Copolymer or Phospholipid Surfactant for the Delivery of Hydrophobic Drugs | FFAR3, FFAR1, FAU | THRB 1404/4885LMNA 2221/4885 |
| US-10758483-B2 | Fluoropolymer emulsions with perhalogenated stabilizer for the delivery of hydrophobic drugs | PFN1, FFAR1, FAU | THRB 2284/4885LMNA 2034/4885 |
| US-20170100336-A1 | Fluoropolymer Emulsions with Perhalogenated Stabilizer for the Delivery of Hydrophobic Drugs | PFN1, FFAR1, FAU | THRB 2284/4885LMNA 2034/4885 |
| US-20200101014-A1 | Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles | EWSR1, TPT1, FOLR1 | THRB 2649/4885LMNA 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.